MedTrace Logo

A Study to Prospectively Assess Disease Progression in Male Children With X-ALD

NCT03278899 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-08-08

No results posted yet for this study

Summary

This is a non-interventional, multi-center study that follows general principles of periodic assessment of X-ALD patients in routine practice. No study drug treatment will be given and no changes to patient treatment are necessary.

Conditions

  • X-Linked Adrenoleukodystrophy

Sponsors & Collaborators

  • NeuroVia, Inc.

    lead INDUSTRY

Principal Investigators

  • John Henderson, MD · NeuroVia, Inc.

Eligibility

Min Age
2 Years
Max Age
13 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-16
Primary Completion
2021-06-01
Completion
2021-06-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03278899 on ClinicalTrials.gov